## Abstract ## __Background.__ The aim of the current study was to identify the antitumor activity of satraplatin in paired cisplatin (CDDP)βresistant oral squamous cell carcinoma (OSCC) cell line and its parental cell line. ## __Methods.__ CDDPβresistant (KBβR) cells and parental cells (KB) pai
The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines
β Scribed by Jackie Perry; Thomas Powles; Jonathan Shamash; Arthi Veerupillai; Eva McGrowder; Elodie Noel; Yong-Jie Lu; Tim Oliver; Simon Joel
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 540 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Since the introduction of cisplatin into the clinic, the treatment of patients with a variety of solid tumors including testicular germ cell tumors, ovarian and lung cancers, has dramatically improved. One of the main causes for therapeutic failure in these malignancies is the developme
We investigated the role of p53 and of the Bcl-2 family proteins in the apoptotic response of a panel of testicular tumour cell lines (NT2, NCCIT, S2 and 2102 EP). The p53 gene status and the capacity of the p53 protein to transactivate the p21/WAF/CIP gene were determined, and we examined the corre
## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##